Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT02868177Phase 2/3Completed
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
DiseaseHypertriglyceridemiaInsulin Resistance+3 more
StudychairStart date: 2016-10-01

Research Network

Collaboration Network

5 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David GENDRE, Dr

Biofortis Mérieux NutriSciences

Very Similar
2 trials

Shared therapeutic areas:

HypertriglyceridemiaDiseaseHypercholesterolemia+4 more

Worked with same sponsors:

Biofortis Mérieux NutriSciencesInstitut Pasteur de Lille+1 more
Collaborated on 2 trials
Similarity Score78%

Sébastien L Peltier, PhD

Valbiotis

Similar
2 trials

Shared therapeutic areas:

DiseaseHypertriglyceridemiaInsulin Resistance+3 more

Worked with same sponsors:

Biofortis Mérieux NutriSciencesInstitut Pasteur de Lille+1 more
Collaborated on 1 trial
Similarity Score64%

Sébastien Peltier, PhD

Valbiotis

Related
2 trials

Shared therapeutic areas:

HypercholesterolemiaHypertriglyceridemia

Worked with same sponsors:

Biofortis Mérieux NutriSciencesValbiotis
Collaborated on 1 trial
Similarity Score24%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Prediabetic StateDiabetes Mellitus, Type 2Hypercholesterolemia+1 more
Similarity Score17%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityInsulin ResistanceDiabetes Mellitus, Type 2+1 more
Similarity Score17%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

HypercholesterolemiaDiabetes Mellitus, Type 2Obesity
Similarity Score13%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2Prediabetic State
Similarity Score13%

Adrian Vella, MD

Mayo Clinic

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2ObesityPrediabetic State
Similarity Score13%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityPrediabetic State
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityInsulin Resistance
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02868177Phase 2/3StudyChair

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

DiseaseHypertriglyceridemiaInsulin Resistance+3 more
Completed
NCT02989753Phase 1/2StudyChair

Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia

HypercholesterolemiaHypertriglyceridemia
Completed

All 2 trials loaded